Literature DB >> 24803409

Expression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque.

Tian Zhou1, Minlu Hu, Andrew Pearlman, Dorothy Patton, Lisa Rohan.   

Abstract

Antiretroviral drug absorption and disposition in cervicovaginal tissue is important for the effectiveness of vaginally or orally administered drug products in preexposure prophylaxis (PrEP) of HIV-1 sexual transmission to women. Therefore, it is imperative to understand critical determinants of cervicovaginal tissue pharmacokinetics. This study aimed to examine the mRNA expression and protein localization of three efflux transporters, P-glycoprotein (P-gp), multidrug resistance-associated protein 4 (MRP4), and breast cancer resistance protein (BCRP), in the lower genital tract of premenopausal women and pigtailed macaques. Along the human lower genital tract, the three transporters were moderately to highly expressed compared to colorectal tissue and liver, as revealed by real-time reverse transcriptase polymerase chain reaction (RT-PCR). In a given genital tract segment, the transporter with the highest expression level was either BCRP or P-gp, while MRP4 was always expressed at the lowest level among the three transporters tested. The immunohistochemical staining showed that P-gp and MRP4 were localized in multiple cell types including epithelial cells and vascular endothelial cells. BCRP was predominantly localized in the vascular endothelial cells. Differences in transporter mRNA level and localization were observed among endocervix, ectocervix, and vagina. Compared to human tissues, the macaque cervicovaginal tissues displayed comparable expression and localization patterns of the three transporters, although subtle differences were observed between the two species. The role of these cervicovaginal transporters in drug absorption and disposition warrants further studies. The resemblance between human and pigtailed macaque in transporter expression and localization suggests the utility of the macaque model in the studies of human cervicovaginal transporters.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24803409      PMCID: PMC4212939          DOI: 10.1089/AID.2013.0281

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  44 in total

Review 1.  Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.

Authors:  Jessica L Adams; Angela D M Kashuba
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-02-04       Impact factor: 5.237

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells.

Authors:  Gunilla Englund; Fredrik Rorsman; Anders Rönnblom; Urban Karlbom; Lucia Lazorova; Johan Gråsjö; Andreas Kindmark; Per Artursson
Journal:  Eur J Pharm Sci       Date:  2006-05-02       Impact factor: 4.384

Review 4.  Targeting early infection to prevent HIV-1 mucosal transmission.

Authors:  Ashley T Haase
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

Review 5.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

Review 6.  Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention.

Authors:  Joseph Romano; Angela Kashuba; Stephen Becker; James Cummins; Jim Turpin; Fulvia Veronese
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-22       Impact factor: 2.205

7.  Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.

Authors:  Salim S Abdool Karim; Angela D M Kashuba; Lise Werner; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

8.  Short communication: expression of transporters and metabolizing enzymes in the female lower genital tract: implications for microbicide research.

Authors:  Tian Zhou; Minlu Hu; Marilyn Cost; Samuel Poloyac; Lisa Rohan
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-17       Impact factor: 2.205

9.  Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer.

Authors:  Naren Gupta; Pamela M Martin; Seiji Miyauchi; Sudha Ananth; Anne V Herdman; Robert G Martindale; Robert Podolsky; Vadivel Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  2006-03-09       Impact factor: 3.575

10.  HIV-1 infection of female genital tract tissue for use in prevention studies.

Authors:  Charlene S Dezzutti; Kevin Uranker; Katherine E Bunge; Nicola Richardson-Harman; Ingrid Macio; Sharon L Hillier
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

View more
  10 in total

Review 1.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

2.  [Depression and anxiety caused by pegylated interferon treatment in patients with chronic hepatitis B and the therapeutic effects of escitalopram and alprazolam].

Authors:  Cheng-Guang Hu; Guo-Sheng Yuan; Hua-Ping Huang; Jun-Wei Liu; Yu-Chen Zhou; Yan-Yu Ren; Yuan Li; Wen-Juan Tan; Mei-Lei Su; Yuan-Ping Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

3.  Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues.

Authors:  Mackenzie L Cottrell; Katy L Garrett; Heather M A Prince; Craig Sykes; Amanda Schauer; Cindi W Emerson; Anne Peery; James F Rooney; Scott McCallister; Cynthia Gay; Angela D M Kashuba
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

Review 4.  Pharmacology of Antiretrovirals in the Female Genital Tract for HIV Prevention.

Authors:  Melanie R Nicol; Joseph A Corbino; Mackenzie L Cottrell
Journal:  J Clin Pharmacol       Date:  2018-06-14       Impact factor: 3.126

5.  Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing.

Authors:  Tian Zhou; Minlu Hu; Andrew Pearlman; Lisa C Rohan
Journal:  Biochem Pharmacol       Date:  2016-07-21       Impact factor: 5.858

6.  Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial Design.

Authors:  Mackenzie L Cottrell; Heather M A Prince; Andrew Allmon; Katie R Mollan; Michael G Hudgens; Craig Sykes; Nicole White; Stephanie Malone; Evan S Dellon; Ryan D Madanick; Nicholas J Shaheen; Kristine B Patterson; Angela D M Kashuba
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-15       Impact factor: 3.731

7.  Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs.

Authors:  Karolin Hijazi; Anna M Cuppone; Kieron Smith; Maria A Stincarelli; Julia Ekeruche-Makinde; Giulia De Falco; Georgina L Hold; Robin Shattock; Charles G Kelly; Gianni Pozzi; Francesco Iannelli
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

Review 8.  The Pre-clinical Toolbox of Pharmacokinetics and Pharmacodynamics: in vitro and ex vivo Models.

Authors:  Carolina Herrera
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

9.  Expression, Activity, and Regulation of Phosphorylating Enzymes in Tissues and Cells Relevant to HIV-1 Sexual Transmission.

Authors:  Minlu Hu; Guru R Valicherla; Tian Zhou; Sharon L Hillier; Lisa C Rohan
Journal:  AIDS Res Hum Retroviruses       Date:  2021-03-09       Impact factor: 2.205

10.  Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial.

Authors:  Charlene S Dezzutti; Nicola Richardson-Harman; Lisa C Rohan; Mark A Marzinke; Craig J Hoesley; Lori Panther; Sherri Johnson; Jeremy P Nuttall; Annalene Nel; Beatrice A Chen
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.